Which peptides have the best evidence for your specific goal.
By Condition & Goal maps the questions people actually ask — which peptides have the best evidence for a torn tendon, for fat loss, for hair, for energy, for libido, for focus — to what the clinical record really supports. Each guide ranks the candidate peptides by evidence strength, not popularity, and is explicit about where the human data stops and the marketing begins.
Wound healing is one of the few peptide areas with genuine human controlled-trial data — but it is narrow, topical, and concentrated in chronic wounds. A clinical-editorial ranking of GHK-Cu, thymosin β4, LL-37 and BPC-157 by what the evidence actually supports in 2026.
An evidence-graded review of the peptides marketed for wrist sprains, tenosynovitis, TFCC tears and carpal tunnel syndrome. The honest 2026 verdict: no human RCT — indeed essentially no human data of any kind — exists; the case is entirely preclinical (rat tendon and sciatic-nerve models), and conventional care has the far stronger human evidence.
Immune, Gut & LongevityEpitalon, MOTS-c, humanin and FOXO4-DRI are marketed as telomere-lengthening, anti-aging peptides. We grade the real evidence — replicated cell-culture data, animal healthspan signals, and the total absence of a qualifying human anti-aging trial.
By Condition & GoalAn evidence-first review of the peptides women are sold for skin, sexual desire, weight, hormones and fertility — graded honestly by human data, with the FDA, WADA and pregnancy cautions marketing leaves out.
Weight Loss & MetabolicThe honest, evidence-first ranking of peptides for weight loss — the GLP-1-based incretin agonists that work in human RCTs, and the 'fat-burning' GH-fragment peptides that failed in human trials.
Injuries & OrthopedicsA clinical, evidence-first ranking of the peptides most promoted for healing surgical incisions and preventing scars — separating genuine human topical-wound data from animal-only signals and marketing.
Sexual & Hormonal HealthThe peptides with real human evidence for raising or protecting endogenous testosterone are the classical reproductive gonadotropins — hCG and LH/FSH — not the boutique 'natural testosterone' research peptides. A ranked, evidence-graded review for 2026.
Skin, Hair & AestheticAn evidence-graded look at the melanocortin 'tanning peptides' — separating the one FDA-approved rare-disease drug (afamelanotide) from the unregulated, illegal-to-sell melanotan-2 'tan jabs' linked to melanoma, priapism and rhabdomyolysis.
Injuries & OrthopedicsTendon is the single best-studied musculoskeletal target for repair peptides — yet no human RCT exists for any peptide in any tendinopathy. We rank BPC-157, TB-500/thymosin β-4 and GHK-Cu strictly by the real evidence.
Weight Loss & MetabolicA clinical-evidence ranking of the peptides that actually reduce visceral (belly) fat — one of the rare peptide topics with genuine Grade A human RCT proof — separating the FDA-approved and investigational incretin/GHRH drugs from the gray-market 'fat-loss' peptides that have none.
Energy, Cognition & MoodAn evidence-ranked look at the peptides marketed for sleep — DSIP, MK-677, epitalon, CJC-1295 and ipamorelin. The honest headline: no peptide is a proven insomnia treatment, and the best human data are tiny and decades old.
Skin, Hair & AestheticA clinical look at copper peptides (GHK-Cu) and Matrixyl for striae distensae. No dedicated human trial exists for either — both grade D for stretch marks specifically, despite stronger data on other skin.
Skin, Hair & AestheticAn evidence-graded look at the melanocortin peptides marketed for a tan or 'natural photoprotection' — separating the one FDA-approved rare-disease drug (afamelanotide) from the unregulated, illegal-to-sell melanotan products linked to melanoma and priapism.
Skin, Hair & AestheticA master, evidence-graded overview of the aesthetic peptide field — GHK-Cu, Matrixyl, Argireline, Synthe'6 and the neuromodulator cast — separating small topical human RCTs from in-vitro mechanism and marketing. The honest ceiling is Grade B.
Skin, Hair & AestheticWhich cosmetic peptides actually soften wrinkles and photoaging — GHK-Cu, Matrixyl, argireline and more — ranked honestly by the human evidence. All are Grade B: modest, topical, delivery-limited, none Grade A.
Sexual & Hormonal HealthA cross-sex, evidence-first overview of the peptides studied for sexual desire, arousal and erectile function — bremelanotide, kisspeptin, melanotan II and oxytocin — graded honestly for men and women. Only one is FDA-approved.
Injuries & OrthopedicsA clinical, evidence-first look at the peptides pitched for rotator-cuff tears, labral injury and shoulder tendinopathy — BPC-157, TB-500/thymosin β-4, and GHK-Cu — and why all three are graded C (preclinical only) for the shoulder.
Injuries & OrthopedicsAn evidence-graded look at the peptides marketed for rotator-cuff tears and repair recovery — BPC-157, TB-500/Thymosin β4 and GHK-Cu — separating a single unpublished rat abstract and animal mechanism from anything resembling human proof.
Immune, Gut & LongevityAn evidence-first ranking of the peptides studied for rheumatoid and autoimmune arthritis — thymosin alpha-1, BPC-157, ARA-290 and KPV — separating real human data from preclinical promise, and flagging the immune-flare risk in a joint-destroying disease.
Energy, Cognition & MoodAn evidence-graded look at the three peptides marketed for PTSD and trauma — oxytocin, Selank and Semax — separating the mixed human oxytocin RCTs from anxiety-only and preclinical claims.
We rank by evidence strength, not by popularity or marketing. For each condition we look at the highest-quality human evidence available — randomized controlled trials first, then cohort and open-label studies — and grade each candidate A-D. A peptide with weak human data but strong rodent results is graded accordingly and ranked below better-evidenced options. Where no peptide has solid human evidence for a goal, we say so plainly rather than implying one works. Every ranking is informational, not a treatment recommendation.
No. These guides are educational and editorial. They explain what the evidence does and does not support for a given condition or goal, but they are not medical advice and they do not prescribe a protocol. Many peptides discussed are not FDA-approved and some are prohibited in sport. Any decision about your health should be made with a licensed clinician who knows your history, not from an article.
Popularity and evidence often diverge. Several heavily marketed peptides — including some best-sellers for injury recovery or fat loss — rest almost entirely on animal studies or anecdote, with no completed human trials. Our grading is conservative, so those compounds rank below peptides with genuine human data even when they are more famous. We always explain the gap between how a peptide is promoted and what has actually been proven in people.
The majority of compounds documented here are not approved by the FDA for human use. Approved drugs (e.g. semaglutide, tirzepatide) are noted explicitly and require a licensed prescriber.
Many peptides — including BPC-157 and GHK-Cu in injectable form — are sold strictly "for research use only — not for human consumption." Purity, identity, and dosing of such products are not regulated or guaranteed.
Several compounds are banned in competitive sport under the WADA Prohibited List. Athletes risk sanction regardless of intent or formulation.
Always consult a qualified, licensed healthcare professional before considering any compound. Individual risk depends on your full medical context.
This content is for informational and educational purposes only · No physician–patient relationship is created · Evidence grades reflect published data as of the stated revision and may change.
